Menu Close

Articles on COVID-19 vaccines

Displaying 301 - 320 of 576 articles

Anita Anand, Canada’s minister of public services and procurement, opens a box with some of the first 500,000 of the two million AstraZeneca COVID-19 vaccine doses that Canada secured last March through a deal with the Serum Institute of India. THE CANADIAN PRESS/Carlos Osorio - POOL

Canada is virtue signalling while waffling on global access to COVID-19 vaccines

Despite some public virtue signalling, the Canadian government is not doing all it can to improve global access to COVID-19 vaccines. Canada has yet to announce its position on the WTO patent waiver.
The US has agreed to ‘free the vaccine’, but will it work? Allison Bailey / Alamy Stock Photo

US-backed vaccine patent waiver: pros and cons explained

It’s not clear whether the TRIPS agreement is what’s getting in the way of vaccine supply, and waiving intellectual property rights may stifle future innovation.
A dose of the one-shot Johnson & Johnson COVID-19 vaccine is prepared at a vaccination event at Baldwin Hills Crenshaw Plaza in South Los Angeles on March 11, 2021. Mario Tama/Getty Images

Restart of the Johnson & Johnson COVID-19 vaccine: A doctor explains why benefits far outweigh risks

The CDC and FDA said the benefits of the Johnson & Johnson vaccine far outweigh the low risk of developing rare blood clots and lifted a pause on the vaccine’s use. A doctor explains.

Top contributors

More